A Pan-Cancer Analysis of Age and Sex Differences in Cancer Incidence and Survival in the United States, 2001–2020
Cancers · 24.01.2025 · 17 (3) · 378
DOI: 10.3390/cancers17030378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.01.2025. Verfasst von Rachel C Selvaraj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI).
Abstract (Originalsprache)
Background
In cancer, age and sex are often studied individually, but the impact of the intersection of these factors on cancer incidence and survival remains unclear. Using population-level data, we provide an up-to-date analysis of the impact of sex and age on cancer incidence and survival.
Methods
Using data from the United States Cancer Statistics public use research database and the Centers for Disease Control and Prevention’s National Program of Cancer Registries Survival database, we assessed sex and age differences in the incidence and survival of malignant cancers diagnosed from 2001 to 2020.
Results
Males experienced higher cancer incidence than females in all sites and age groups, excluding 20–29- and 30–39-year-olds. The highest Male-to-female (M:F) age-adjusted incidence rates (IRR) were observed in mesothelioma within ages 80+ (IRR: 5.48; 95% CI: 5.25–5.71; p < 0.001), and lowest in endocrine cancer within ages 20–29 years (M:F IRR: 0.20; 95% CI: 0.20–0.21; p < 0.001). Among all sites and age groups, excluding 0–9 years, males experienced worse survival than females, particularly within ages 20–29 years (Hazard Ratio (HR): 2.19; 95% CI: 2.15–2.23; p < 0.001). Highest M:F HRs were observed in endocrine system cancers within ages 20–29 (HR: 3.52; 95% CI: 3.15–3.94; p < 0.001), and lowest among lymphomas within ages 0–9 (HR: 0.74; 95% CI: 0.63–0.87; p < 0.001).
Conclusions
Significant age and sex differences in cancer incidence and survival were observed across the US from 2001 to 2020. Males had a higher cancer incidence compared to females, with notable exceptions for younger age groups among certain types, suggesting age may be a critical component in further understanding the biology of sex differences in cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Department of Statistics, University of Illinois Urbana-Champaign, Champaign, IL 61820, USA.
- Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD 20892, USA.
ORCID-Profile: Kristin A Waite, Sarah S Jackson, Jill S Barnholtz-Sloan
Förderung
- Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI)
Zitieren
APA
Selvaraj, R. C., Cioffi, G., Waite, K. A., Jackson, S. S., & Barnholtz-Sloan, J. S. (2025). A Pan-Cancer Analysis of Age and Sex Differences in Cancer Incidence and Survival in the United States, 2001–2020. Cancers, 17(3), 378. https://doi.org/10.3390/cancers17030378
Vancouver
Selvaraj RC, Cioffi G, Waite KA, Jackson SS, Barnholtz-Sloan JS. A Pan-Cancer Analysis of Age and Sex Differences in Cancer Incidence and Survival in the United States, 2001–2020. Cancers. 2025;17(3):378. doi:10.3390/cancers17030378
BibTeX
@article{Selvaraj2025,
author = {Selvaraj, Rachel C and Cioffi, Gino and Waite, Kristin A and Jackson, Sarah S and Barnholtz-Sloan, Jill S},
title = {A Pan-Cancer Analysis of Age and Sex Differences in Cancer Incidence and Survival in the United States, 2001–2020},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {378},
doi = {10.3390/cancers17030378}
}
EUVIMED